Globus Medical Stock Surges

Globus Medical has received the CE mark for its Excelsius3D imaging system, a significant development for the company. The CE mark approval is for the EU market, allowing Globus Medical to expand its reach in the region. Globus Medical's stock rose following the EU approval for the imaging system, indicating a positive response from investors. ## Why it matters The CE mark is a crucial certification for medical devices in the EU, and receiving it is a significant milestone for Globus Medical. The approval and subsequent rise in stock value demonstrate the company's growing presence in the medical technology market. The Excelsius3D imaging system is now cleared for use in the EU, which could lead to increased adoption and revenue for Globus Medical.